Therapy News and Research

RSS

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.

19 Oct 2023

CAR T-cell therapy for multiple myeloma shows no difference in survival outcomes by race and ethnicity

Patients with multiple myeloma treated with idecabtagene vicleucel, known as "ide-cel," a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of race and ethnicity, according to a study published in Blood Advances.

19 Oct 2023

Common challenges when seeking market access for rare disease therapies

In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth & Strategy at AscellaHealth about the recurring challenges met when seeking market access for rare disease therapies.

From AscellaHealth, LLC. 19 Oct 2023

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

The use of vitamin E and selenium in preventing the recurrence and progression of NMIBC.

19 Oct 2023

Study explores sex-specific effects in Alzheimers disease pathology

The role of biological sex in the development and progression of Alzheimer's Disease (AD).

19 Oct 2023

How does diet impact rosacea and acne?

The associations between diet, rosacea, and acne.

19 Oct 2023

One in five Norwegians suffering from inadequate tinnitus treatment

Researchers have concluded that many people are suffering unnecessarily and that treatment provision offered to patients is failing at many levels.

18 Oct 2023

Research reveals new way viruses suppress the CRISPR-Cas immune systems of bacteria

A microscopic discovery will not only enable scientists to understand the microbial world around us but could also provide a new way to control CRISPR-Cas biotechnologies.

18 Oct 2023

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer - both of which helped patients live longer without their disease progressing than the current standard treatment.

18 Oct 2023

Microscale device for eye implantation may be used in the treatment of diabetes

Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and other diseases.

18 Oct 2023

Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.

18 Oct 2023

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.

18 Oct 2023

Lung chip model offers new insights into how radiation damages the lungs

The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of many cell types in the lung, causing acute and sustained inflammation, and in the longer term, the thickening and scarring of lung tissue known as fibrosis.

17 Oct 2023

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).

17 Oct 2023

Late-breaking studies could change the treatment landscape for women with gynecological cancers

Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress 2023 in Madrid, Spain.

17 Oct 2023

Gut microbiota linked to Alzheimer's disease

Researchers have discovered the link between the gut microbiota and Alzheimer's disease.

17 Oct 2023

Researchers receive NCI grant for the development of new pancreatic cancer therapies

Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.

17 Oct 2023

Can exercise, intermittent fasting help patients better tolerate side effects from breast cancer treatment?

Can lifestyle interventions such as exercise and intermittent fasting help patients with advanced breast cancer better tolerate side effects from treatment?

17 Oct 2023

FAST joins with University of Pennsylvania to develop investigational AAV gene therapy for Angelman syndrome

The Foundation for Angelman Syndrome Therapeutics (FAST) announced today that the non-profit organization has entered into an exclusive global collaborative research and development agreement with the University of Pennsylvania to develop an investigational adeno-associated virus (AAV) gene therapy for Angelman syndrome (AS).

17 Oct 2023

New communication tool reduces sick leave in patients with Medically Unexplained Physical Symptoms

Medically Unexplained Physical Symptoms (MUPS) are characterized by persistent bodily symptoms and functional impairment that lack an explanation through known medical condition or pathology.

17 Oct 2023

Therapy News and Research

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

CAR T-cell therapy for multiple myeloma shows no difference in survival outcomes by race and ethnicity

Common challenges when seeking market access for rare disease therapies

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

Study explores sex-specific effects in Alzheimers disease pathology

How does diet impact rosacea and acne?

One in five Norwegians suffering from inadequate tinnitus treatment

Research reveals new way viruses suppress the CRISPR-Cas immune systems of bacteria

Scientists identify two promising new treatment options for men with recurrent prostate cancer

Microscale device for eye implantation may be used in the treatment of diabetes

Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Lung chip model offers new insights into how radiation damages the lungs

New treatment options offer hope for patients with non-small cell lung cancer

Late-breaking studies could change the treatment landscape for women with gynecological cancers

Gut microbiota linked to Alzheimer's disease

Researchers receive NCI grant for the development of new pancreatic cancer therapies

Can exercise, intermittent fasting help patients better tolerate side effects from breast cancer treatment?

FAST joins with University of Pennsylvania to develop investigational AAV gene therapy for Angelman syndrome

New communication tool reduces sick leave in patients with Medically Unexplained Physical Symptoms

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News